Cancer Options Blog

This blog is a way of sharing, supporting and educating anyone dealing with a cancer-related illness about the options and treatments they have at their disposal.

You're browsing: Home » Blog » Uncategorized » Blog article: Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

Are Prostate Needle Biopsies Predictive Of The Laterality Of Significant Cancer And Positive Surgical Margins?

This Article was Written September 11th, 2009

Powered by Gregarious (39)

Are Prostate Needle Biopsies Predictive Of The

Laterality Of Significant Cancer And Positive

Surgical Margins?

UroToday.com - In the online edition of the British Journal of Urology International, Dr. Rodrigo Frota presents the single surgeon laparoscopic radical prostatectomy (LRP) experience of Dr. Inderbir Gill. The study is a retrospective review with the intent of correlating preoperative needle biopsy and final specimen pathological data to determine if the laterality of a positive biopsy should influence the surgeon’s decision for ipsilateral nerve-sparing.Data included 490 LRP patients operated on between 2002 and 2006. None had received androgen-deprivation therapy and all had clinically localized prostate cancer (CaP). Prostate biopsy specimens were all internally reviewed and on prostatectomy analysis cancer volume was defined as low when it was <0.5cc, medium when between 0.5 and 2.0cc and extensive when >2.0cc. A focal positive surgical margin (PSM) was defined as a solitary site of malignant cells at any inked margin, and extensive PSM as multiple sites of involvement. Significant CaP in the specimen was defined as medium or extensive volume (>0.5cc) or any Gleason grade 4. The dominant biopsy side was defined as the only prostate lobe with disease for unilaterally positive biopsy cases and the lobe with the most positive biopsy cores for bilateral cases.

The median number of prostate biopsies performed per patient was 10.3 and the median number of cores positive for CaP was 2.84. Unilateral and bilateral nerve-sparing was performed in 14% and 59% of patients, respectively. Extracapsular extension (ECE) was found in 11 men (23%) with bilateral ECE in 51 men (10%). In patients with cancer only in the right prostate lobe on biopsy, 10% had a PSM or ECE on the left lobe. When CaP was only present in the left lobe on biopsy, PSM, ECE or significant CaP in the right lobe on final pathology was found in 12%, 8%, and 7%, respectively. Final Gleason score was unchanged from biopsy in 59%, upgraded in 35% and downgraded in 6%. A PSM was found in 21%, but in only 11% if intraoperative TRUS guidance was used. Most PSMs were apical (60%).

For unilaterally positive biopsies, concordance with laterality of any CaP on prostatectomy was 19% on the right and 12% on the left side. Thus only minor agreement existed between biopsy laterality and laterality of any CaP on final prostatectomy pathology. There was only minor agreement between biopsy laterality and laterality of significant CaP on final pathology. The number of prostate biopsy cores taken did not matter in influencing the laterality with final specimen pathology. Only minor agreement existed between laterality of a positive biopsy and laterality of PSMs.

In patients with dominant CaP in the right lobe on biopsy, a PSM occurred on the same side in 58%, but in 42% it occurred on the left side. If the left lobe had the dominant CaP on biopsy, a PSM occurred on the right side in 49% and on the left side in 39%. Thus only a minor correlation exists between laterality of CaP on prostate biopsy and laterality of significant CaP on final prostatectomy specimen.

Frota R, Stein RJ, Turna B, Kamoi K, Lin YC, Magi-Galluzzi C, Aron M, Gill IS
BJU Int. 2009 Jul 2. Epub ahead of print.
doi:10.1111/j.1464-410X.2009.08648.x

Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2009 - UroToday

Powered by Gregarious (39)

PLEASE post a comment below

  • Categories

  • Subscribe

    All posts by all authors Google Reader or Homepage Subscribe Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online Add to My AOL Subscribe in Rojo Add to Technorati Favorites!
    Business Blogs - BlogCatalog Blog Directory

    Enter your email address:

    Comments (RSS)

  • Random Posts & Pages

    All About Robot-Assisted Prostate Surgery

  • What Should You Know About FascinatingTreatment Option?By Matthew Schmitz, M.D., About.com GuideCreated: November 19, 2009About.com Health's Disease and Condition content is reviewed by the Medical Review BoardRobot-assisted prostate surgery is a relatively new treatment option for prostate cancer. So what do you need to know about this fascinating surgical option?How Does Robot-Assisted Prostate
  • MRI combo spots prostate cancer treatment failure

  • Two imaging modalities used in combination -- dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging (DWI)-MRI -- can accurately spot residual or recurrent prostate cancer in patients treated with a fairly new treatment called high-intensity focused ultrasonic ablation, a new study shows.Together these two imaging modalities are better than
  • Research shows that soy decreases the risk of breast and prostate cancers

  • A new soy protein-packed, low-fat, high-fiber cereal meets the requirements for three different FDA health claims and leaves you feeling full so you won't be tempted to eat again until lunch.University of Illinois scientist Soo-Yeun Lee has a recipe for just such a cereal, one that's passed the taste test
  • Man-A-Grams Urged For Prostate Cancer

  • Man-A-Grams Urged For Prostate Cancer By Will DunhamWASHINGTON JAN 14, 2009 (Reuters) - Prostate cancer experts urged the U.S. Congress and the incoming Obama administration on Wednesday to make a major research commitment to find better detection methods, including what they call a "man-o-gram." Their idea involves a sophisticated ultrasound, magnetic resonance
  • Proxcelan™ with Cesium-131 advantages

  • Proxcelan™ (Cesium-131) brachytherapy seeds offer patients unique advantages over other medical isotopes. Increasingly, prostate cancer patients and their doctors who decide on seed brachytherapy choose Cesium-131 treatment because of its significant advantages over Palladium-103 and Iodine-125, two other isotopes currently in use. These advantages include Higher Energy, Shorter Half-Life,
  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading

  • New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading ScienceDaily (Feb. 12, 2009) — Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading. In experiments reported in the journal Nature, the
  • ASTRO: Brachytherapy Called Prostate Cancer Option for Younger Men

  • By Michael Smith, Senior Staff Writer, MedPage Today Published: October 31, 2007 Reviewed by Zalman S. Agus, MD; Emeritus Professor at the University of Pennsylvania School of Medicine. LOS ANGELES, Oct. 31 -- Younger men with prostate cancer benefit just as much from brachytherapy as older men, a researcher said here.Younger age is often thought
  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes

  • Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes ScienceDaily (Jan. 2, 2009) — In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this
  • Green Tea Component May Slow Prostate Cancer

  • Green Tea Component May Slow Prostate Cancer Men in small study took capsules equivalent to brewed beverage Friday, June 19 (HealthDay News) -- The active compounds in green tea might slow the progression of prostate cancer, the results of a small study suggest. The study included 26 men, 41 to 72 years old,
  • New Web Site Helps Doctors And Prostate Cancer Patients Make Better Treatment Choices

  • ScienceDaily (Sep. 23, 2008) — Doctors have created a free online computer tool, the CaP Calculator, that provides cancer specialists access to the latest prostate cancer research and helps them better individiualize each patient's treatment options, according to a study presented in a scientific session on September, 23, 2008, at


  •  

    July 2010
    M T W T F S S
    « Jan    
     1234
    567891011
    12131415161718
    19202122232425
    262728293031